Selection and interpretation of clinical pathology indicators of hepatic injury in preclinical studies.
about
Characterization of chemically induced liver injuries using gene co-expression modulesPhospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrug-resistant tumors.Evaluation of clinical pathology data: correlating changes with other study data.Diagnostic performance of traditional hepatobiliary biomarkers of drug-induced liver injury in the rat.Effects of hepatic drug-metabolizing enzyme induction on clinical pathology parameters in animals and man.Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on hormones of energy balance in a TCDD-sensitive and a TCDD-resistant rat strain.Protective effect of quercetin on melphalan-induced oxidative stress and impaired renal and hepatic functions in rat.Hematological and histopathological effects of swainsonine in mouse.Evaluation of the efficacy and safety of a marine-derived Bacillus strain for use as an in-feed probiotic for newly weaned pigs.Metabolic adaptive ALT isoenzyme response in livers of C57/BL6 mice treated with dexamethasoneDisparate metabolic effects of blackcurrant seed oil in rats fed a basal and obesogenic diet.The Rat microRNA body atlas; Evaluation of the microRNA content of rat organs through deep sequencing and characterization of pancreas enriched miRNAs as biomarkers of pancreatic toxicity in the rat and dogAnatomic, hematologic, and biochemical features of C57BL/6NCrl mice maintained on chronic oral corticosterone.Quercetin, a Flavonoid Antioxidant, Ameliorated Procarbazine-Induced Oxidative Damage to Murine Tissues.Recommendations for Clinical Pathology Data Generation, Interpretation, and Reporting in Target Animal Safety Studies for Veterinary Drug Development.Toxicity Studies of Ethyl Maltol and Iron Complexes in Mice.The role of the toxicologic pathologist in the biopharmaceutical industry.Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes--conclusions from the 3rd International ESTP Expert Workshop.Development of blood biomarkers for drug-induced liver injury: an evaluation of their potential for risk assessment and diagnostics.Best practices for veterinary toxicologic clinical pathology, with emphasis on the pharmaceutical and biotechnology industries.The efficacy of raw and concentrated bentonite clay in reducing the toxic effects of aflatoxin in broiler chicks.Long-term toxicity study on genetically modified corn with cry1Ac gene in a Wuzhishan miniature pig model.Mito-Apocynin Prevents Mitochondrial Dysfunction, Microglial Activation, Oxidative Damage, and Progressive Neurodegeneration in MitoPark Transgenic Mice.Principles for Assessing Adversity in Toxicologic Clinical Pathology.STP Best Practices for Evaluating Clinical Pathology in Pharmaceutical Recovery Studies.Influence of Fasciola hepatica on Serum Biochemical Parameters and Vascular and Biliary System of Sheep Liver.Value of shared preclinical safety studies - The eTOX database.Campomanesia adamantium (Myrtaceae) fruits protect HEPG2 cells against carbon tetrachloride-induced toxicity.Comparison of ketamine-xylazine and ketamine-dexmedetomidine anesthesia and intraperitoneal tolerance in rats.Impact of therapeutic and high doses of florfenicol on kidney and liver functional indicators in goat.Profiling of dihydroorotate dehydrogenase, p38 and JAK inhibitors in the rat adjuvant-induced arthritis model: a translational studyInvestigation of correlation among safety biomarkers in serum, histopathological examination, and toxicogenomics.An updated and simplified method for bile duct cannulation of rats.Protective effect of Chresta martii extract against indomethacin-induced gastric lesions in mice.Quantitative rat liver function test by galactose single point method.Veterinary clinical pathologists in the biopharmaceutical industry.Dynamics of liver enzymes in rabbits experimentally infected with Fasciola sp. (Intermediate form from Japan).Toxicologic characterization of a novel explosive, guanidinium 3,4-dinitropyrazolate (GDNP), in female rats and Ames mutagenicity assay.Blood parameters in fattening pigs fed whole-ear corn silage and housed in group pens or in metabolic cages.Effect of feeding genetically modified Bt MON810 maize to ∼40-day-old pigs for 110 days on growth and health indicators.
P2860
Q28543001-A419E7AA-EDA4-45F0-94D5-1834A049BCB9Q30403731-27AE046F-BD30-4E80-A008-E0F06B57CA88Q30866423-675ED597-BA02-4139-9111-4837AE7FCAC1Q33577715-4006D5AC-6F46-4F1C-A054-8B3F0E9CE86BQ33618803-03541811-3E8A-483D-822A-37EAE2AB01B2Q34158496-A49BE306-CCC0-4C32-AB82-19787B2E6D8CQ34773920-7B68B9CE-8A83-4F56-89A1-8561EAD6DDE2Q35105513-22B72FD9-3857-4F94-9C90-DCE43CBB449EQ35106157-75705F02-2EC5-4507-A700-82E0CB000A1AQ35966141-552A513D-7E85-40AD-AFBB-DA1D2557F5CDQ35967988-36C6C4A5-C3A8-4AD0-A2F6-0D72C19F203DQ36117391-C899FCA7-F6D7-404B-910F-A565EE0A6DC4Q36321357-91D3E4C6-5520-430D-8B1C-C5F9761331A2Q36335014-84BC1DFF-D9E0-46E6-89B7-8F0E98C219D6Q36393197-661B7F78-0995-41B4-BDAB-ED08169A33A7Q37620300-DE29A555-6DE3-4736-9820-F7B81BA50B0FQ37924048-529F8857-5D12-4488-A48A-664B902D7C9CQ38020789-BD0BF157-074D-4CC3-9348-5C76D2303656Q38122649-D2589554-A381-4652-A409-528FA692AA69Q38124352-118509A1-B071-4FE7-A48F-9279439EBFE6Q38406742-58A7AE62-C0F9-462E-A346-B441A2FF7DD4Q38802588-86154349-F33F-4D82-A115-8DBD11738250Q38855994-80F0B7DE-BB64-48ED-B162-CDB7BDE4E6DFQ39037976-E1FF4729-0B62-4DE6-9E12-54F904D56D1BQ39995176-C72746FF-BD39-41D1-A577-527CE1F60E0AQ40746237-21CA4751-76BF-4FF7-B0E3-DEFCC87B236FQ41680722-23DBD9F6-90D7-403E-B382-491AEB528607Q41680733-F8A38591-4CCD-4998-A2DE-C437B1D0968CQ41867147-7F64F450-9DD8-4F27-B142-84385357FBA6Q41921703-AD04D9B6-3750-4AC1-B219-5EED6B885E77Q42272947-80E240AB-075E-4305-8057-25D6FECB0D5FQ42732620-02ED227B-7A4A-450B-830A-8A13E969CDE1Q42927108-ACA246DF-4390-45D4-9B92-33F14ED18C45Q45326462-73026162-6CDC-4F43-924A-D490B1F47160Q46327275-69B5966D-61F5-429C-8453-9BFA4239FCFAQ48340003-E346EC5A-4AAF-45EA-B01E-A00A86C70144Q49434843-7A850D66-06CC-4531-80AB-22CB2E2392C4Q50025198-431AEACF-08D8-419E-B8A3-1B0F188D499BQ50435989-793F0F0B-22CA-4414-8668-334415D55B1DQ52744512-F23DCAD3-AB89-43D0-95B7-7F5F40767EEB
P2860
Selection and interpretation of clinical pathology indicators of hepatic injury in preclinical studies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Selection and interpretation o ...... injury in preclinical studies.
@ast
Selection and interpretation o ...... injury in preclinical studies.
@en
type
label
Selection and interpretation o ...... injury in preclinical studies.
@ast
Selection and interpretation o ...... injury in preclinical studies.
@en
prefLabel
Selection and interpretation o ...... injury in preclinical studies.
@ast
Selection and interpretation o ...... injury in preclinical studies.
@en
P2093
P1476
Selection and interpretation o ...... injury in preclinical studies.
@en
P2093
A Provencher Bolliger
P304
P356
10.1111/J.1939-165X.2005.TB00041.X
P577
2005-09-01T00:00:00Z